Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 5Terminated 3Completed 3Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Stomach Neoplasms 6Peritoneal Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 3Pancreatic Neoplasms 2Neoplasms 2Gastric Adenocarcinoma 2Colorectal Neoplasms 2Uterine Neoplasms 1Stomach Diseases 1Pseudomyxoma Peritonei 1Peritoneal Diseases 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Colonic Neoplasms 1Appendiceal Neoplasms 1

Interventions

Carboplatin 18Paclitaxel 17Bevacizumab 17olaparib 8Specimen Handling 7liposomal doxorubicin 6pembrolizumab 5Taxes 5Biopsy 5cemiplimab 4Magnetic Resonance Spectroscopy 4sarilumab 3niraparib 3mirvetuximab soravtansine 3Topotecan 3Standard of Care 3Letrozole 3Gemcitabine 3Cisplatin 3130-nm albumin-bound paclitaxel 3taxane 2talazoparib 2palbociclib 2abemaciclib 2Temozolomide 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Poly(ADP-ribose) Polymerase Inhibitors 2Immunoglobulin G 2Fulvestrant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fallopian Tube Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT05415709 2026-02-11

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
45 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡